Mok and Scagliotti: What You Need to Know About Afatinib
A Skype conversation between Drs. Tony Mok and Giorgio Scagliotti details the efficacy and potential toxicities of afatinib, which is newly approved by the FDA for EGFR-positive lung cancer patients.
Source: Medscape Pathology and Laboratory Medicine Podcast - Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
More News: Cancer | Cancer & Oncology | Laboratory Medicine | Lung Cancer | Pathology | Podcasts | Toxicology